New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2013
09:12 EDTAFDA approves two Dako assays
Dako, an Agilent Technologies company, announced it has received approval from the FDA for the addition of Kadcyla in the labeling of two Dako companion diagnostic assays. Kadcyla is Genentech's new medicine for patients with HER2-positive metastatic breast cancer who have received prior treatment with Genentech's cancer medicine Herceptin and a taxane chemotherapy. The two assays are Dako's HercepTest and HER2 IQFISH pharmDx.
News For A From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 25, 2015
10:01 EDTAOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:28 EDTAAgilent upgraded to Buy from Neutral at BTIG
Subscribe for More Information
07:18 EDTAG Corp to hold annual meeting
Subscribe for More Information
February 19, 2015
09:09 EDTALeerink's life science tools analyst holds an analyst/industry conference call
Subscribe for More Information
February 17, 2015
16:09 EDTAAgilent sees FY15 EPS $1.67- $1.73, consensus $1.73
Subscribe for More Information
16:08 EDTAAgilent sees Q2 EPS 37c-41c, consensus $39c
Subscribe for More Information
16:07 EDTAAgilent reports Q1 EPS 41c, consensus 41c
Subscribe for More Information
15:32 EDTANotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Devon Energy (DVN), consensus $1.05... Vornado Realty (VNO), consensus $1.23... Analog Devices (ADI), consensus 61c... FirstEnergy (FE), consensus 75c... CF Industries (CF), consensus $5.08... Agilent Technologies (A), consensus 41c... Cimarex Energy (XEC), consensus 82c... Flowserve (FLS), consensus $1.13... Fossil (FOSL), consensus $3.07... Rackspace (RAX), consensus 19c... Norwegian Cruise Line (NCLH), consensus 37c... Jack in the Box (JACK), consensus 87c... Cloud Peak Energy (CLD), consensus 7c... La-Z-Boy (LZB), consensus 38c... KAR Auction Services (KAR), consensus 29c... Owens & Minor (OMI), consensus 50c... Valmont Industries (VMI), consensus $1.65... Realty Income (O), consensus 66c.
February 16, 2015
10:54 EDTADako and Ono Pharmaceutical announce collaboration
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, and Ono Pharmaceutical announced a new partnership to develop a potential diagnostic test specifically for use with Opdivo in the treatment of non-small cell lung cancer, NSCLC. This test is being investigated for its diagnostic utility to determine which patients are most likely to respond to Opdivo.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use